FDA News

Endovascular device for aortic dissection approved, launched

March 29, 2019
Cook Medical announced that its endovascular device to repair type B aortic dissections was recently approved by the FDA and was used for the first…

Meeting News

DCBs not beneficial in below-the-knee lesions

March 28, 2019
Compared with plain balloons, drug-coated balloons did not improve patency and were associated with worse 12-month rates of amputation-free survival…

Feature

Vessel Preparation May Be Key to Treating Challenging Peripheral Lesions

Cardiology Today's Intervention, March/April 2019
Endovascular interventions are becoming more common in patients with peripheral artery disease and critical limb ischemia, even in complex lesions…

The Take Home

The Take Home: ISET

Cardiology Today's Intervention, March/April 2019
The International Symposium on Endovascular Therapy (ISET) was held Jan. 27 to 30 in Hollywood, Florida, and Cardiology Today’s

The Big Picture

Peripheral, Structural Developments Poised to Change Practice

Cardiology Today's Intervention, March/April 2019
Lawrence Garcia, MD
In recent months, there have been many impressive CV advancements as several trials have shed light on issues affecting our patients that are…

Meeting News

Role of atherectomy in endovascular interventions up for debate

March 16, 2019
NEW ORLEANS — Atherectomy appears to have its place in practice, but experts remain somewhat divided over how judiciously the procedure should…

FDA NewsPerspective

FDA recommends temporary halt to use of paclitaxel-coated devices in most patients with PAD

March 15, 2019
The FDA warned that using paclitaxel-coated products in the treatment of peripheral arterial disease in the femoropopliteal artery may increase…

Meeting News

Highlights from ISET: Paclitaxel controversy, LIBERTY 360° and more

March 13, 2019
The International Symposium on Endovascular Therapy featured discussions of some of the hottest topics in vascular intervention, including the…

Shockwave attracts additional investment from Abiomed, has IPO

March 12, 2019
Shockwave Medical announced it received a $10 million investment from Abiomed, which comes several months after a $15 million investment from the…

FDA News

FDA takes active role in paclitaxel controversy, recalls

March 11, 2019
FDA Commissioner Scott Gottlieb, MD, recently announced that he will be stepping down, leaving behind a legacy of great activity during his term. …

Meeting News

Aspiration-based extraction technique beneficial for AF, peripheral arterial occlusions

March 11, 2019
HOLLYWOOD, Fla. — Patients with atrial fibrillation experienced good outcomes after treatment with an aspiration-based extraction technique…

In the JournalsPerspective

Potentially harmful radiation doses occur in 1 of 14 PAD procedures

March 6, 2019
One in 14 patients who undergoes endovascular intervention for lower-extremity peripheral artery disease receives a radiation dose large enough to…

In the Journals

Paclitaxel-coated balloon effective in peripheral CTOs at 1 year

March 5, 2019
A paclitaxel-coated balloon treated peripheral chronic total occlusions safely and effectively at 1 year, according to new data from the IN.PACT…

Meeting News

Preliminary FDA analysis finds paclitaxel-related mortality signal

March 4, 2019
An FDA official announced at a special meeting that the agency’s preliminary analysis of the possible link between paclitaxel-coated devices…

Top intervention news of February: DAPT duration, paclitaxel controversy updates and more

March 3, 2019
Cardiology Today’s Intervention and Healio Intervention compiled a list of the most-read intervention articles posted in February. This month…

In the Journals

PES not tied to 2-year mortality risk in real-world population

March 1, 2019
In a retrospective analysis of CMS beneficiaries with peripheral artery disease followed for 2 years, paclitaxel-eluting stents were not associated…

In the Journals

Lesion morphology predicts complications in balloon pulmonary angioplasty for CTEPH

February 27, 2019
Lesion morphology was the only independent predictor of complications in balloon pulmonary angioplasty procedures to treat chronic thromboembolic…

In the Journals

Motivational interviewing fails to raise walking distance in black adults with PAD

February 22, 2019
Motivational interviewing was not effective in improving walking distance for black adults with peripheral artery disease in either 6- or 12-month…

In the Journals

Depression confers amputation, mortality risk in PAD

February 20, 2019
Among patients with peripheral artery disease, those with depression had greater risk for amputation and mortality than those without PAD…

In the Journals

No evidence of paclitaxel-related mortality risk in real-world PAD cohort

February 18, 2019
In a cohort of CMS beneficiaries with peripheral artery disease, there was no evidence that those revascularized with a drug-coated device had…